| P50 | author | Monika Fleshner | Q38590235 |
| P2093 | author name string | Benjamin N Greenwood | |
| | Paul V Strong | |
| P2860 | cites work | Acute selective serotonin reuptake inhibitors increase conditioned fear expression: blockade with a 5-HT(2C) receptor antagonist | Q24684698 |
| | 5-HT2 receptor activation in the midbrain periaqueductal grey (PAG) reduces anxiety-like behaviour in mice | Q28253222 |
| | Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists | Q28278816 |
| | Serotonin 5-HT2C receptors as a target for the treatment of depressive and anxious states: focus on novel therapeutic strategies | Q28293380 |
| | Genetic variation in cortico-amygdala serotonin function and risk for stress-related disease | Q30487278 |
| | Effects of centrally administered anxiolytic compounds in animal models of anxiety | Q33540480 |
| | Influence of the 5-HT2C receptor antagonist, SB-242084, in tests of anxiety | Q34117794 |
| | 5-HT1c receptor is a prominent serotonin receptor subtype in the central nervous system | Q34302096 |
| | Evidence that mCPP-induced anxiety in the plus-maze is mediated by postsynaptic 5-HT2C receptors but not by sympathomimetic effects. | Q34327187 |
| | Localization of the 5-hydroxytryptamine2C receptor protein in human and rat brain using specific antisera. | Q34395395 |
| | SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist | Q34432766 |
| | CP-809,101, a selective 5-HT2C agonist, shows activity in animal models of antipsychotic activity | Q34562888 |
| | Antidepressant-like effects of the novel, selective, 5-HT2C receptor agonist WAY-163909 in rodents | Q34575450 |
| | 5-Hydroxytryptamine2C receptor contribution to m-chlorophenylpiperazine and N-methyl-beta-carboline-3-carboxamide-induced anxiety-like behavior and limbic brain activation | Q34653174 |
| | Exercise, learned helplessness, and the stress-resistant brain | Q34755419 |
| | Anxiety-like behaviors produced by acute fluoxetine administration in male Fischer 344 rats are prevented by prior exercise | Q35167108 |
| | The neurobiology and control of anxious states | Q35202929 |
| | Behavioral control, the medial prefrontal cortex, and resilience | Q35236897 |
| | Learned helplessness is independent of levels of brain-derived neurotrophic factor in the hippocampus | Q35741506 |
| | Serotonin, the periaqueductal gray and panic | Q35822444 |
| | Stressor controllability and learned helplessness: the roles of the dorsal raphe nucleus, serotonin, and corticotropin-releasing factor | Q36127587 |
| | Previous experience with behavioral control over stress blocks the behavioral and dorsal raphe nucleus activating effects of later uncontrollable stress: role of the ventral medial prefrontal cortex. | Q39271534 |
| | Use of serotonergic agents in the clinical assessment of central serotonin function | Q39730231 |
| | 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: More than 30 years of research | Q40465103 |
| | Role of the amygdala and periaqueductal gray in anxiety and panic | Q40729187 |
| | Immunohistochemical localisation of the 5-HT2C receptor protein in the rat CNS. | Q40901462 |
| | Role of 5-HT in stress, anxiety, and depression. | Q41052750 |
| | 6-Chloro-5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]-5-pyridyl]carbamoyl]- indoline (SB-242084): the first selective and brain penetrant 5-HT2C receptor antagonist | Q41081403 |
| | Dual role of 5-HT in defense and anxiety | Q41672215 |
| | Freewheel running prevents learned helplessness/behavioral depression: role of dorsal raphe serotonergic neurons. | Q42439467 |
| | Anxiogenic-like effects of mCPP microinfusions into the amygdala (but not dorsal or ventral hippocampus) in mice exposed to elevated plus-maze. | Q42608283 |
| | Anxiolytic properties of the selective, non-peptidergic CRF(1) antagonists, CP154,526 and DMP695: a comparison to other classes of anxiolytic agent | Q43737575 |
| | Role of fear in mediating shuttle escape learning deficit produced by inescapable shock | Q43804783 |
| | Serotonin 5- HT (2C) receptor knockout mice: autoradiographic analysis of multiple serotonin receptors | Q43831286 |
| | Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635. | Q43863844 |
| | 5-HT2C receptor mediation of unconditioned escape behaviour in the unstable elevated exposed plus maze | Q44196920 |
| | Brain region-specific alterations of 5-HT2A and 5-HT2C receptors in serotonin transporter knockout mice | Q44339812 |
| | Serotonin 2C receptors within the basolateral amygdala induce acute fear-like responses in an open-field environment | Q44671980 |
| | Effect of number of tailshocks on learned helplessness and activation of serotonergic and noradrenergic neurons in the rat. | Q46507484 |
| | Serotonergic systems associated with arousal and vigilance behaviors following administration of anxiogenic drugs. | Q46510078 |
| | Activation of the serotonin 5-HT2C receptor is involved in the enhanced anxiety in rats after single-prolonged stress | Q46859474 |
| | Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors | Q48149092 |
| | Chlordiazepoxide microinjected into the region of the dorsal raphe nucleus eliminates the interference with escape responding produced by inescapable shock whether administered before inescapable shock or escape testing | Q48179075 |
| | Activation of serotonin-immunoreactive cells in the dorsal raphe nucleus in rats exposed to an uncontrollable stressor | Q48228048 |
| | The role of the amygdala and dorsal raphe nucleus in mediating the behavioral consequences of inescapable shock | Q48308817 |
| | 5-HT2 receptor mechanisms of the dorsal periaqueductal gray in the conditioned and unconditioned fear in rats. | Q48318130 |
| | Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: a comparison with diazepam and buspirone | Q48383010 |
| | Effects of acute and subchronic treatments with fluoxetine and desipramine on the memory of fear in moderate and high-intensity contextual conditioning | Q48475382 |
| | Exposure to inescapable but not escapable shock increases extracellular levels of 5-HT in the dorsal raphe nucleus of the rat. | Q48482061 |
| | The effects of chronic treadmill and wheel running on behavior in rats | Q48529334 |
| | Distribution of the 5-hydroxytryptamine2C receptor protein in adult rat brain and spinal cord determined using a receptor-directed antibody: effect of 5,7-dihydroxytryptamine | Q48632854 |
| | Neuroanatomical targets of anxiogenic drugs in the hindbrain as revealed by Fos immunocytochemistry. | Q51079466 |
| | mCPP-induced anxiety in the light-dark box in rats--a new method for screening anxiolytic activity. | Q51098050 |
| | The dorsal raphe nucleus is a site of action mediating the behavioral effects of the benzodiazepine receptor inverse agonist DMCM. | Q51122690 |
| | 8-OH-DPAT microinjected in the region of the dorsal raphe nucleus blocks and reverses the enhancement of fear conditioning and interference with escape produced by exposure to inescapable shock. | Q51124130 |
| | Exposure to the stressor environment prevents the temporal dissipation of behavioral depression/learned helplessness. | Q52135989 |
| | Librium prevents the analgesia and shuttlebox escape deficit typically observed following inescapable shock. | Q52271807 |
| | Comparative localization of serotonin1A, 1C, and2 receptor subtype mRNAs in rat brain | Q60681181 |
| P433 | issue | 4 | |
| P921 | main subject | learned helplessness | Q618018 |
| P1104 | number of pages | 11 | |
| P304 | page(s) | 665-675 | |
| P577 | publication date | 2008-11-27 | |
| P1433 | published in | Psychopharmacology | Q1422802 |
| P1476 | title | The effects of the selective 5-HT(2C) receptor antagonist SB 242084 on learned helplessness in male Fischer 344 rats | |
| P478 | volume | 203 | |